Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

RESMED INC Director's Dealing 2010

Feb 9, 2010

30071_dirs_2010-02-09_6c8e5c26-9df0-4e16-ba23-ebe7a0eab7d6.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2010-02-05

Reporting Person: FARRELL PETER C (Director, Executive Chairman)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2010-02-05 ResMed Common Stock S 10000 $55.09 Disposed 539374 Direct
2010-02-08 ResMed Common Stock G 10000 $0.00 Disposed 529374 Direct

Footnotes

F1: Trade executed pursuant to 10b5-1.

F2: Transaction is a gift to the Peter C. Farrell Charitable Remainder Trust. Dr. Farrell does not have sole or shared investment control over the trust.